国邦医药：股东协议转让公司股份完成过户

Group 1 - The core point of the news is that Guobang Pharmaceutical has completed a share transfer agreement with a state-owned operating company, involving approximately 38.31 million shares, which accounts for 6.85% of the company's total shares [1] - The shareholders involved in the transfer are Shiqihui, Hong Dehui, and Shi Qingde, who are transferring their shares of approximately 27.45 million, 10.23 million, and 630,000 shares respectively [1] - The share transfer was confirmed by the Shanghai Stock Exchange on September 23, 2025, and the transfer registration was completed on September 29, 2025 [1] Group 2 - For the year 2024, Guobang Pharmaceutical's revenue composition is as follows: the pharmaceutical segment accounts for 64.87%, the animal health products segment accounts for 34.24%, and other businesses account for 0.88% [2] - As of the latest report, Guobang Pharmaceutical has a market capitalization of 12.4 billion yuan [3]